The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHICL Infrastructure Regulatory News (HICL)

Share Price Information for HICL Infrastructure (HICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 126.00
Bid: 126.20
Ask: 126.40
Change: -0.60 (-0.47%)
Spread: 0.20 (0.158%)
Open: 126.00
High: 127.40
Low: 125.80
Prev. Close: 126.60
HICL Live PriceLast checked at -
HICL Infrastructure is an Investment Trust

To deliver a long-term, stable income to shareholders from a diversified portfolio of infrastructure investments positioned at the lower end of the risk spectrum.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Disposal for c. £204m

28 Sep 2023 07:00

RNS Number : 8883N
HICL Infrastructure PLC
28 September 2023
 

28 September 2023

 

HICL Infrastructure PLC

"HICL" or "the Company" and, together with its subsidiaries, "the Group", the London-listed infrastructure investment company managed by InfraRed Capital Partners Limited ("InfraRed" or "the Investment Manager".)

Portfolio Disposal for c. £204m

 

· Sale of five UK assets at a premium to HICL's 31 March 2023 valuation

· c.£310m of accretive disposals announced since March 2023

· Reduces revolving credit facility drawings to c. £130m at completion

 

The Board is pleased to announce that HICL has agreed to dispose of a portfolio of five assets to John Laing, an international core infrastructure investor. The portfolio is made up of HICL's entire equity interest in four UK PPP projects; Queens (Romford) Hospital, Oxford John Radcliffe Hospital ("OJR"), Priority Schools North East Batch and South Ayrshire Schools, in addition to half of its investment in the Hornsea II OFTO2.

 

The total consideration for the transaction is c. £204m, which represents a small premium to the Company's last audited valuation for the relevant assets at 31 March 2023. This accretive transaction evidences the robustness of the Company's net asset value, improves portfolio construction, and enhances the key metrics of yield, inflation correlation and asset life. The partial sell-down of the recently acquired Hornsea II OFTO was envisaged at the time of acquisition and demonstrates responsible balance sheet management against a challenging market environment.

 

Completion of all five disposals is expected before HICL's 31 March 2024 year-end. The transaction proceeds will reduce the drawings on the Company's Revolving Credit Facility to c. £130m.

 

The largest of the five assets1, OJR, was developed by Carillion plc under the private finance initiative and HICL acquired its interests in 2010 and 2012. Following the liquidation of Carillion in 2018, InfraRed's asset management team led the project restructuring to successfully resolve all outstanding contractual obligations with the NHS client, replace the facilities management service providers and subsequently remediate outstanding defects. As a result of HICL's ownership, the project has been stabilised and de-risked, and maintains strong relationships with key stakeholders.

Edward Hunt, Head of Core Income Funds at InfraRed said:

"This accretive sale of a representative cross-section of HICL's portfolio further demonstrates the disconnect between public and private market valuations for high-quality infrastructure assets. Since 31 March 2023 the Company has realised over £300m from asset disposals demonstrating effective capital recycling while enhancing key portfolio metrics and reducing gearing."

1 Using Directors' valuation as at 31 March 20232 Post completion, HICL will retain a 37.5% equity stake in Hornsea II OFTO

 

-Ends-

 

Enquiries

InfraRed Capital Partners Limited +44 (0) 20 7484 1800 / info@hicl.com

Edward Hunt

Helen Price

Mohammed Zaheer

 

Brunswick +44 (0) 20 7404 5959 / hicl@brunswickgroup.com

Sofie Brewis

 

Investec Bank plc +44(0) 20 7597 4952

David Yovichic

 

RBC Capital Markets +44 (0) 20 7653 4000

Matthew Coakes

Elizabeth Evans

 

Aztec Financial Services (UK) Limited +44(0) 203 818 0246

Chris Copperwaite

Sarah Felmingham

 

HICL Infrastructure PLC

HICL Infrastructure PLC ("HICL") is a long-term investor in infrastructure assets which are predominantly operational and yielding steady returns. It was the first infrastructure investment company to be listed on the London Stock Exchange.

With a current portfolio of over 100 infrastructure investments, HICL is seeking further suitable opportunities in core infrastructure, which are inherently positioned at the lower end of the risk spectrum.

Further details can be found on the HICL website www.hicl.com.

 

Investment Manager (InfraRed Capital Partners)

The Investment Manager to HICL is InfraRed Capital Partners Limited ("InfraRed") which has successfully invested in infrastructure projects since 1997. InfraRed is a leading international investment manager, operating worldwide from offices in London, New York, Seoul and Sydney and managing equity capital in multiple private and listed funds, primarily for institutional investors across the globe. InfraRed is authorised and regulated by the Financial Conduct Authority.

The infrastructure investment team at InfraRed consists of over 100 investment professionals, all with an infrastructure investment background and a broad range of relevant skills, including private equity, structured finance, construction, renewable energy and facilities management.

InfraRed implements best-in-class practices to underpin asset management and investment decisions, promotes ethical behaviour and has established community engagement initiatives to support good causes in the wider community. InfraRed is a signatory of the Principles of Responsible Investment.

Further details can be found on InfraRed's website www.ircp.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISLRMFTMTATBMJ
Date   Source Headline
13th Jun 20178:44 amRNSAnnual General Meeting Circular
13th Jun 20177:00 amRNSAnnual General Meeting Circular
13th Jun 20177:00 amRNSAnnual Financial Report
5th Jun 20173:22 pmRNSResult of Equity Issue
2nd Jun 20171:24 pmRNSScrip Share Reference Price
24th May 20177:00 amRNSAnnual Results for the year ended 31 March 2017
24th May 20177:00 amRNSIssue of Equity
22nd May 20177:00 amRNSCompletion of Acquisition
18th May 201711:21 amRNSFourth Quarterly Interim Dividend
2nd May 20177:00 amRNSAcquisition of a new investment
2nd May 20177:00 amRNSIncrease in the Group's credit facility
10th Apr 20177:00 amRNSNotice of Annual Results
5th Apr 20174:00 pmRNSDirector/PDMR Shareholding
4th Apr 201710:28 amRNSHolding(s) in Company
3rd Apr 20178:00 amRNSIncremental Investment
31st Mar 20175:11 pmRNSTotal Voting Rights
29th Mar 20174:00 pmRNSDirector/PDMR Shareholding
24th Mar 20178:00 amRNSAdditional Listing and Total Voting Rights
22nd Mar 20174:00 pmRNSDirector/PDMR Shareholding
22nd Mar 201710:16 amRNSAdditional Listing
22nd Mar 20177:00 amRNSResult of Equity Issue
21st Mar 20179:28 amRNSTerms and Conditions of the Placing
20th Mar 201711:49 amRNSDirectorate Change
20th Mar 201711:36 amRNSResults of EGM
10th Mar 20178:00 amRNSCompletion of Acquisition
9th Mar 20172:37 pmRNSScrip Share Reference Price
23rd Feb 20175:41 pmRNSPublication of a Prospectus and Circular
23rd Feb 20175:00 pmRNSPublication of a Prospectus and Circular
22nd Feb 20174:45 pmRNSThird Quarterly Interim Dividend
2nd Feb 201711:44 amRNSInterim Update Statement February 2017
23rd Jan 20177:00 amRNSCompletion of Acquisition
12th Jan 20172:42 pmRNSIntention to issue new equity
5th Jan 20177:00 amRNSCompletion of Two Acquisitions
4th Jan 20174:00 pmRNSDirector/PDMR Shareholding
30th Dec 20164:00 pmRNSTotal Voting Rights
16th Dec 201612:32 pmRNSAdditional Listing
7th Dec 20163:45 pmRNSDirector/PDMR Shareholding
2nd Dec 201610:00 amRNSDirector Declaration - Additional Directorship
2nd Dec 20168:00 amRNSConditional Acquisition of a new investment
2nd Dec 20167:55 amRNSIncrease in the Group's credit facility
1st Dec 20162:27 pmRNSScrip Share Reference Price
29th Nov 201612:50 pmRNSPublication of Interim Report
23rd Nov 20167:00 amRNSCompletion of Acquisition
16th Nov 20167:00 amRNSInterim Results Six Months Ended 30 September 2016
10th Nov 201611:47 amRNSSecond Quarterly Interim Dividend
24th Oct 20167:00 amRNSNotice of Interim Results
4th Oct 20164:30 pmRNSDirector/PDMR Shareholding
30th Sep 20163:00 pmRNSTotal Voting Rights
22nd Sep 20162:00 pmRNSResult of Equity Issue
21st Sep 20161:40 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.